Atlas Trials

The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder

Clinical trial NCT03487198 · TERMINATED

Trial details

NCT number
NCT03487198
Sponsor
Otsuka Beijing Research Institute
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2018-05-30
Primary completion
2019-05-30
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.